tiprankstipranks
Chemcon Speciality Chemicals Ltd (IN:CHEMCON)
:CHEMCON
India Market
Want to see IN:CHEMCON full AI Analyst Report?

Chemcon Speciality Chemicals Ltd (CHEMCON) AI Stock Analysis

1 Followers

Top Page

IN:CHEMCON

Chemcon Speciality Chemicals Ltd

(CHEMCON)

Select Model
Select Model
Select Model
Outperform 71 (OpenAI - 5.2)
Rating:71Outperform
Price Target:
₹229.00
▲(10.44% Upside)
Action:Upgraded
Date:06/06/26
The score is driven primarily by solid financial footing and improved FY2026 cash generation, tempered by significant margin compression that weakens profitability. Technicals are supportive with an established uptrend, while valuation is a mild headwind due to a higher P/E despite a decent dividend yield.
Positive Factors
Low leverage / strong balance sheet
Chemcon's very low debt-to-equity (~0.11) provides durable financial flexibility, lowering refinancing and solvency risk. This conservative capital structure supports steady operations, enables selective capex or bolt-on investments, and cushions the business versus cyclical downturns over 2–6 months.
Negative Factors
Material margin compression
A sharp decline in gross and net margins signals weakened pricing power, adverse product mix, or rising input costs that compress profitability. If structural, lower margins reduce returns, limit reinvestment capacity and raise sensitivity to cost cycles across the next several quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / strong balance sheet
Chemcon's very low debt-to-equity (~0.11) provides durable financial flexibility, lowering refinancing and solvency risk. This conservative capital structure supports steady operations, enables selective capex or bolt-on investments, and cushions the business versus cyclical downturns over 2–6 months.
Read all positive factors

Chemcon Speciality Chemicals Ltd (CHEMCON) vs. iShares MSCI India ETF (INDA)

Chemcon Speciality Chemicals Ltd Business Overview & Revenue Model

Company Description
Founded in 1988 and headquartered in Vadodara, India, Chemcon Speciality Chemicals Limited is a producer and vendor of a diverse range of chemical products. The company primarily focuses on manufacturing pharmaceutical intermediates, silanes, and ...
How the Company Makes Money
Chemcon makes money primarily by manufacturing specialty chemicals and selling them to customers (B2B) in India and overseas. Its revenue model is transaction-based: (1) product sales of specialty chemicals (including chemical ingredients/intermed...

Chemcon Speciality Chemicals Ltd Financial Statement Overview

Summary
Low leverage supports stability (debt-to-equity ~0.11) and FY2026 cash flow rebounded strongly (OCF ~501.5M; FCF ~409.6M). However, profitability weakened materially with sharp margin compression (gross margin ~21.9% vs ~41.9% in FY2025; net margin ~9.8% vs ~11.8%), and cash flow has been volatile historically (negative FCF in FY2023–FY2024).
Income Statement
62
Positive
Balance Sheet
78
Positive
Cash Flow
70
Positive
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue2.17B2.40B2.07B2.67B3.01B2.57B
Gross Profit881.31M524.77M869.50M758.95M1.27B1.17B
EBITDA432.71M301.72M328.58M400.64M840.11M908.34M
Net Income248.87M235.98M244.52M191.93M551.10M627.57M
Balance Sheet
Total Assets5.48B5.68B5.54B5.45B5.53B4.98B
Cash, Cash Equivalents and Short-Term Investments1.25B1.96B1.51B230.80M604.87M1.12B
Total Debt2.62M531.37M246.90M427.39M640.15M360.20M
Total Liabilities350.98M844.38M532.81M688.34M959.98M808.06M
Stockholders Equity5.13B4.83B5.01B4.76B4.57B4.17B
Cash Flow
Free Cash Flow285.20M409.59M309.45M-308.77M-334.54M241.36M
Operating Cash Flow356.48M501.51M405.17M119.64M127.43M742.22M
Investing Cash Flow11.03M-460.09M-189.15M-245.58M-163.41M-925.48M
Financing Cash Flow-248.62M-8.79M-215.42M-247.73M120.41M298.18M

Chemcon Speciality Chemicals Ltd Technical Analysis

Technical Analysis Sentiment
Positive
Last Price207.35
Price Trends
50DMA
171.78
Positive
100DMA
164.50
Positive
200DMA
192.14
Negative
Market Momentum
MACD
6.62
Positive
RSI
55.29
Neutral
STOCH
24.70
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:CHEMCON, the sentiment is Positive. The current price of 207.35 is above the 20-day moving average (MA) of 191.94, above the 50-day MA of 171.78, and above the 200-day MA of 192.14, indicating a neutral trend. The MACD of 6.62 indicates Positive momentum. The RSI at 55.29 is Neutral, neither overbought nor oversold. The STOCH value of 24.70 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:CHEMCON.

Chemcon Speciality Chemicals Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
₹7.20B30.4615.71%-3.48%
66
Neutral
₹2.45B18.811.11%-39.14%-65.08%
65
Neutral
₹12.88B18.290.52%21.13%18.86%
64
Neutral
₹8.68B18.0515.32%158.73%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
47
Neutral
₹8.95B-32.620.56%7.26%-293.26%
47
Neutral
₹1.52B54.150.37%13.01%67.31%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:CHEMCON
Chemcon Speciality Chemicals Ltd
196.50
10.65
5.73%
IN:BODALCHEM
Bodal Chemicals Limited
68.95
-2.87
-4.00%
IN:CHEMBOND
Chembond Chemicals Limited
181.85
-41.93
-18.74%
IN:ESTER
Ester Industries Limited
91.67
-36.61
-28.54%
IN:HPIL
Hindprakash Industries Ltd.
132.95
2.65
2.03%
IN:SHREEPUSHK
Shree Pushkar Chemicals & Fertilisers Ltd.
398.35
90.04
29.20%

Chemcon Speciality Chemicals Ltd Corporate Events

Chemcon clears FY26 results, announces interim dividend and renews audit appointments
May 21, 2026
Chemcon Speciality Chemicals’ board has approved the audited financial statements and results for the quarter and full year ended 31 March 2026, with its statutory auditors issuing an unmodified opinion, underscoring the reliability of the c...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 06, 2026